Immune surveillance of EBV-infected B cells and the development of non-Hodgkin lymphomas in immunocompromised patients.
about
Inflammatory bowel disease and cancer: The role of inflammation, immunosuppression, and cancer treatmentThiopurines and inflammatory bowel disease: Current evidence and a historical perspectiveImmune Activation: Contribution to AIDS-Associated Non-Hodgkin LymphomaAdverse events in IBD: to stop or continue immune suppressant and biologic treatmentUpdate on the risk of lymphoma following immunosuppressive therapy for inflammatory bowel disease.Burkitt lymphoma: pathogenesis and immune evasion.Epstein-Barr virus replication linked to B cell proliferation in inflamed areas of colonic mucosa of patients with inflammatory bowel diseaseCurrent status of immunotherapy for the treatment of lung cancer.Effect of Medications on Risk of Cancer in Patients With Inflammatory Bowel Diseases: A Population-Based Cohort Study from Olmsted County, MinnesotaExploiting the interplay between innate and adaptive immunity to improve immunotherapeutic strategies for Epstein-Barr-virus-driven disordersRapid reconstitution of CD4 T cells and NK cells protects against CMV-reactivation after allogeneic stem cell transplantation.Oral eosinophilic ulcer, an Epstein-Barr virus-associated CD30+ lymphoproliferation?Lymphoma in inflammatory bowel disease and treatment decisions.Sequential Hodgkin's and non-Hodgkin's lymphoma in non-immunocompromised patients.Xenophagy in Helicobacter pylori- and Epstein-Barr virus-induced gastric cancer.Monitoring for Extra-Intestinal Cancers in IBD.The Effect of Antiretroviral Combination Treatment on Epstein-Barr Virus (EBV) Genome Load in HIV-Infected Patients.Immediate Antiretroviral Therapy Reduces Risk of Infection-Related Cancer During Early HIV Infection.Malaria, Epstein-Barr virus infection and the pathogenesis of Burkitt's lymphoma.HIV Co-receptor usage in HIV-related non-hodgkin's lymphoma.Controlled Epstein-Barr virus reactivation after allogeneic transplantation is associated with improved survival.Differences in Virological and Immunological Risk Factors for Non-Hodgkin and Hodgkin Lymphoma.Association between oral lichen planus and Epstein-Barr virus in Iranian patients.
P2860
Q26745456-FB30C1DE-0C19-443A-9660-7A6FB4C9CB3DQ28079644-A3D6F5F4-C1B9-4725-A466-DE3DEDB41EF7Q33887336-8DEF4346-C771-4ABB-A3D1-39485B695F41Q34073191-32E0416B-DE6B-4BB5-9759-DB108827E145Q34078707-C8A912A3-AA51-4CD9-AAAD-CC5081054132Q34189497-10D56E89-5271-4B31-971F-1ED5C98C378EQ34644510-3B922054-1E73-4A36-A311-FBF68745EA77Q35667739-EC265E85-D60E-408D-8536-BA4D96E0E869Q35690314-FD6C4C83-A088-426C-8662-1C228141DA18Q35738744-C35EED7C-0E27-453C-934B-20253611C624Q37148363-096482CA-F31C-41D0-9838-3AF3C34AC105Q37861459-021592C9-C32A-4E90-AD02-98F06527EB4AQ38024070-41DC9160-711F-4B9D-A8F1-04596BDF6198Q38096296-F7D7C478-440F-4034-8A9F-C2DD7F40A617Q38196348-D4BCE04F-AFCA-468A-A1E9-5E9A7E251C85Q38585910-D0E89B65-B8B3-406B-A21C-C16644767A9FQ38615024-D9F1177F-DD1E-4C08-8710-936C8EE02745Q38853095-4885E6BE-F1AD-4DBF-97DC-4727CD281B66Q40123116-14FA2692-0F07-48CF-977E-349D11CF1539Q42138493-B0602E03-1934-4028-804B-C30282E7027DQ42244554-47445BBB-126B-4851-B749-50F81C7DDF5CQ47266595-280B2767-1F5A-4A6C-AF62-361254006D58Q54228581-FC78AB4E-DABC-462A-9E87-DE1C4EB83DBF
P2860
Immune surveillance of EBV-infected B cells and the development of non-Hodgkin lymphomas in immunocompromised patients.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Immune surveillance of EBV-inf ...... in immunocompromised patients.
@en
Immune surveillance of EBV-inf ...... in immunocompromised patients.
@nl
type
label
Immune surveillance of EBV-inf ...... in immunocompromised patients.
@en
Immune surveillance of EBV-inf ...... in immunocompromised patients.
@nl
prefLabel
Immune surveillance of EBV-inf ...... in immunocompromised patients.
@en
Immune surveillance of EBV-inf ...... in immunocompromised patients.
@nl
P2093
P2860
P1433
P1476
Immune surveillance of EBV-inf ...... in immunocompromised patients.
@en
P2093
Debbie van Baarle
Erwan Piriou
Floor Pietersma
P2860
P304
P356
10.1080/10428190801911662
P577
2008-06-01T00:00:00Z